Know Cancer

or
forgot password
  • cancer clinical trials in connecticut

  • Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

    Trial Locations
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Norwalk Hospital
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Hartford Hospital

    Trial Locations
    Hartford Hospital
    Yale University
    Stamford Hospital
    Connecticut Oncology and Hematology LLP
    Breast Cancer
    Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Breast Cancer
    Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
    Praxair Cancer Center at Danbury Hospital

    Trial Locations
    Praxair Cancer Center at Danbury Hospital
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Helen and Harry Gray Cancer Center at Hartford Hospital
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    Lung Cancer
    Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
    University of Connecticut Health Center
    Farmington, Connecticut 06360-7106
    Sickle Cell Disease, Vaso-occlusive Crisis, Pain Crisis
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Kidney Cancer
    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma
    Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Acral Lentiginous Malignant Melanoma, Lentigo Maligna Malignant Melanoma, Nodular Malignant Melanoma, Recurrent Melanoma, Solar Radiation-related Skin Melanoma, Stage IV Melanoma, Superficial Spreading Malignant Melanoma
    Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
    Middlesex Hospital Cancer Center

    Trial Locations
    Middlesex Hospital Cancer Center
    Yale Cancer Center
    Breast Cancer
    Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Cancer
    Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Hartford Hospital

    Trial Locations
    Hartford Hospital
    The Hospital of Central Connecticut
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma
    Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Manchester Memorial Hospital

    Trial Locations
    Manchester Memorial Hospital
    The Hospital of Central Connecticut
    Yale University
    Eastern Connecticut Hematology and Oncology Associates
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
    Yale Cancer Center
    New Haven, Connecticut 06520-8028
    Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer
    Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
    University of Connecticut

    Trial Locations
    University of Connecticut
    Yale University
    Estrogen Receptor-positive Breast Cancer, Stage III Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Neoadjuvant Therapy for Ovarian Cancer
    Yale University
    New Haven, Connecticut 06520
    Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Praxair Cancer Center at Danbury Hospital

    Trial Locations
    Praxair Cancer Center at Danbury Hospital
    Bendheim Cancer Center at Greenwich Hospital
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Middlesex Hospital Cancer Center
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    Yale Cancer Center
    Norwalk Hospital
    Colorectal Cancer
    Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Head and Neck Cancer, Mucositis, Oral Complications of Radiation Therapy, Pain
    A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
    Jeremy Ethan Moss, MD, FACP

    Trial Locations
    Jeremy Ethan Moss, MD, FACP
    The Savin Center, P.C.
    New England Research Associates, Llc
    Psoriasis
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Danbury Hospital

    Trial Locations
    Danbury Hospital
    Hartford Hospital
    Saint Francis Hospital and Medical Center
    The Hospital of Central Connecticut
    Yale University
    Eastern Connecticut Hematology and Oncology Associates
    Stamford Hospital
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
    The Hospital of Central Connecticut
    New Britain, Connecticut 06050
    Recurrent Uterine Sarcoma, Uterine Carcinosarcoma
    A Study of Chemotherapy and Ramucirumab vs. Chemotherapy Alone in Second Line Non-small Cell Lung Cancer Participants Who Received Prior First Line Platinum Based Chemotherapy
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Stamford, Connecticut 06902
    Non Small Cell Lung Cancer
    Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Danbury Hospital

    Trial Locations
    Danbury Hospital
    Saint Francis Hospital and Medical Center
    Light Chain Deposition Disease, Smoldering Multiple Myeloma